{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:52:19Z","timestamp":1791060739717,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.cgh.2013.04.050","type":"journal-article","created":{"date-parts":[[2013,5,20]],"date-time":"2013-05-20T13:52:47Z","timestamp":1369057967000},"page":"1466-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Clinical Factors Associated With Development of Severe-Complicated Clostridium difficile Infection"],"prefix":"10.1016","volume":"11","author":[{"given":"Raina","family":"Shivashankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahil","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia P.","family":"Kammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Zinsmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry M.","family":"Baddour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell S.","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2013.04.050_bib1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile: more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2013.04.050_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ajg.2011.398","article-title":"The epidemiology of community-acquired Clostridium difficile infection: a population-based study","volume":"107","author":"Khanna","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.04.050_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/egh.10.48","article-title":"The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings","volume":"4","author":"Khanna","year":"2010","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.04.050_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2013.04.050_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/658336","article-title":"Comparison of clinical severity score indices for Clostridium difficile infection","volume":"32","author":"Fujitani","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2013.04.050_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhin.2011.04.017","article-title":"CSI: a severity index for Clostridium difficile infection at the time of admission","volume":"79","author":"Lungulescu","year":"2011","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cgh.2013.04.050_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF02054220","article-title":"Severe Clostridium difficile colitis","volume":"38","author":"Rubin","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.cgh.2013.04.050_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/427113","article-title":"A\u00a0hospital outbreak of Clostridium difficile disease associated with isolates\u00a0carrying binary toxin genes","volume":"40","author":"McEllistrem","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2013.04.050_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/506349","article-title":"Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea","volume":"43","author":"Louie","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2013.04.050_bib10","first-page":"495","article-title":"Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system","volume":"55","author":"Belmares","year":"2007","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cgh.2013.04.050_bib11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2013.04.050_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2036.2008.03914.x","article-title":"Predictors of serious complications due to Clostridium difficile infection","volume":"29","author":"Gujja","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.04.050_bib13","series-title":"Program and abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy","article-title":"Results of a phase III trial comparing tolevamer, vancomycin and metronidazole in Clostridium difficile-associated diarrhea (CDAD)","author":"Louie","year":"2007"},{"key":"10.1016\/j.cgh.2013.04.050_bib14","unstructured":"University of Pittsburgh Medical Center. Guide to antimicrobial chemotherapy. 4th ed. 2008. Available at: http:\/\/www.residency.dom.pitt.edu\/Hcorner\/Documents\/AntimicrobialGuide2008.pdf. Accessed November\u00a02011."},{"key":"10.1016\/j.cgh.2013.04.050_bib15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MCG.0b013e3182432273","article-title":"An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction","volume":"46","author":"Khanna","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2013.04.050_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.urology.2010.02.069","article-title":"Prediction of mortality after radical prostatectomy by Charlson Comorbidity Index","volume":"76","author":"Guzzo","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.cgh.2013.04.050_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cid\/cir404","article-title":"Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections","volume":"53","author":"Mullane","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2013.04.050_bib18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2012.05022.x","article-title":"Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease","volume":"35","author":"Ananthakrishnan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2013.04.050_bib19","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/cid\/cir668","article-title":"Risk factors associated with complications and mortality in patients with Clostridium difficile infection","volume":"53","author":"Morrison","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2013.04.050_bib20","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cgh.2006.03.002","article-title":"Serious infections\u00a0and mortality in association with therapies for Crohn's disease: TREAT registry","volume":"4","author":"Lichtenstein","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2013.04.050_bib21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1155\/2011\/153020","article-title":"Reducing the risk of severe complications among patients with Clostridium difficile infection","volume":"25","author":"Manek","year":"2011","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cgh.2013.04.050_bib22","first-page":"91","article-title":"Serum markers for severe Clostridium difficile infection in immunosuppressed hospitalized patients","volume":"163","author":"Pant","year":"2011","journal-title":"J\u00a0La State Med Soc"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651300685X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651300685X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:12:35Z","timestamp":1761541955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651300685X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S154235651300685X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2013.04.050","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Factors Associated With Development of Severe-Complicated Clostridium difficile Infection","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2013.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}